Your next cup of coffee may come from a lab
Biotech company, Pluri, launches branch dedicated to cell-based coffee grown in labs to cut coffee production’s water usage by 98%.
Biotech company, Pluri, launches branch dedicated to cell-based coffee grown in labs to cut coffee production’s water usage by 98%.
A new cell therapy platform finds potential applications in a variety of industries from pharma to food tech.
A letter from the CEO of Pluristem to multiethnic staff urging love and acceptance has gone viral as people find strength and comfort in his words.
Pluristem and Abu Dhabi Stem Cells Center to collaborate in developing cell therapies and regenerative drugs for severe diseases including Covid-19.
Israeli scientists, doctors, innovators, and CEOs are working quickly, with purpose, and fully aware of the huge responsibility they are undertaking.
Regenerative medicine firm Pluristem gets €50 million venture debt loan, recently treated Covid-19 patients with its placenta-derived product.
Pluristem’s innovative treatment — PLX-R18 – could save lives of severely ill patients with hematopoietic disorders.
Fukushima Medical University signs deal with Pluristem Therapeutics to further develop the company’s PLX-R18 cells to treat acute radiation syndrome.
Pluristem is focusing on the expansion of hematopoietic stem cells (HSC) from umbilical cord blood, which can be used for bone marrow transplants.